Allogeneic haematopoietic stem cell transplantation (allo-HSCT) is one of the most aggressive treatments for haematological disorders. The procedure requires high doses of chemotherapy, and in some cases radiation, to eradicate the disease; this has a significant impact on patients' quality of life (Mosher, Redd, Rini, Burkhalter, and DuHamel, 2009). Despite the potentially curative effects of this treatment, psychosocial distress often results from regimen-related toxicities, long periods of isolation, lengthy in-hospital stays, a range of symptoms induced by graft-versus-host disease (GVHD) and long-lasting complications(Brice et al., 2017; Cooke, Gemmill, Kravits, & Grant, 2009). However, despite these stressors, there are limited evidence-based psychological interventions for allo-HSCT survivors (Baliousis, Rennoldson, & Snowden, 2016). To develop these interventions, specific information is needed regarding survivor appraisal of stressors and coping strategies. Thus, a qualitative analysis of survivors' views is appropriate and useful. We reviewed previous qualitative studies describing stress and coping among adult allo-HSCT survivors by using PubMed, Web of Science and Google Scholar; 'haematopoietic stem cell transplantation' 'stress' 'coping"' "qualitative"' were used as keywords; hand searching was also performed. Previous studies have categorised allo-HSCT survivors' stressors into the following three